Certain subsets of type 1 regulatory cells and CD4+ T-helper cells produced when IL-10 is present from intra-tumoral myeloid cells use cytotoxic T lymphocyte-inhibitory functions and perform a similar role in the context of HCC [36]. This evidence concerns the gene IL10 and hepatocellular carcinoma.